ACTA1 and metabolic dysfunction-associated steatohepatitis: The number of αSMA+ pericentral HSCs was increased in NASH biopsies in comparison with SS ones (Table 2; p = 0.024); similarly, the number of αSMA+ portal/septal MFs was increased in NASH in comparison with SS biopsies (Table 2; p = 0.034).